[Blood coagulation in newborns (author's transl)].
This article gives a survey of the physiology of blood coagulation in newborn infants, subdivided into the particularities of the plasmic coagulation system and the fibronolysis. Etiology, diagnosis and therapy of the consumption coagulopathy as well as the coagulopathy of production are dealed with.
D001778:Blood Coagulation Disorders; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000628:therapy; D005260:Female; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000235:genetics; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008107:Liver Diseases / Q000150:complications; D008833:Microcirculation; D010952:Plasma Substitutes / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D013300:Streptokinase / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use; D014813:Vitamin K Deficiency / Q000151:congenital
D001779:Blood Coagulation Factors; D010952:Plasma Substitutes; D014812:Vitamin K; D006493:Heparin; D011239:Prednisolone; D013300:Streptokinase
Gerinnungsprobleme bei Neugeborenen